Uta Kiltz (U Kiltz)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 99

Top Topics

Magnetic Resonance

Ankylosing Spondylitis

Disease Activity

Top Venues

Annals of the rheumatic diseases

The Journal of rheumatology

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases (2024)
Maarten P T de Wit, Krystel Aouad, Muriel Elhai, Diego Benavent, Heidi Bertheussen, Steven Blackburn, Peter Böhm, Catia Duarte, Marie Falahee, Susanne Karlfeldt, Uta Kiltz, Elsa F Mateus, Dawn P Richards, Javier Rodriguez-Carrio, Joachim Sagen, Russka Shumnalieva, Simon R Stones, Sander W Tas, William Tillett, Ana Vieira, Tanita-Christina Wilhelmer, Condruta Zabalan, Jette Primdahl, Paul Studenic, Laure Gossec
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update. Annals of the rheumatic diseases (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Joerg Christoph Henes, Jutta G Richter, Katja Thiele, Uta Kiltz, Johanna Callhoff, Katinka Albrecht
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021. Rheumatology international (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (8) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Buehring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis. Therapeutic advances in musculoskeletal disease 16 (2024)
Maarten P T de Wit, Krystel Aouad, Muriel Elhai, Diego Benavent, Heidi Bertheussen, Steven Blackburn, Peter Böhm, Catia Duarte, Marie Falahee, Susanne Karlfeldt, Uta Kiltz, Elsa F Mateus, Dawn P Richards, Javier Rodriguez-Carrio, Joachim Sagen, Russka Shumnalieva, Simon R Stones, Sander W Tas, William Tillett, Ana Vieira, Tanita-Christina Wilhelmer, Condruta Zabalan, Jette Primdahl, Paul Studenic, Laure Gossec
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update. Annals of the rheumatic diseases (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Joerg Christoph Henes, Jutta G Richter, Katja Thiele, Uta Kiltz, Johanna Callhoff, Katinka Albrecht
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021. Rheumatology international 44 (3) (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, David Kiefer, Ioana Andreica, Björn Buehring, Jüergen Braun, Uta Kiltz
A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases. Arthritis research & therapy 26 (1) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
Joerg Christoph Henes, Jutta G Richter, Katja Thiele, Uta Kiltz, Johanna Callhoff, Katinka Albrecht
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021. Rheumatology international 44 (3) (2024)
Joerg Christoph Henes, Jutta G Richter, Katja Thiele, Uta Kiltz, Johanna Callhoff, Katinka Albrecht
Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021. Rheumatology international 44 (3) (2024)
Fabian Proft, Murat Torğutalp, Burkhard Muche, Valeria Rios Rodriguez, Joachim Listing, Mikhail Protopopov, Judith Rademacher, Hildrun Haibel, Laura Spiller, Anne-Katrin Weber, Maryna Verba, Jan Brandt-Juergens, Uta Kiltz, Maren Sieburg, Swen Jacki, Joachim Sieper, Denis Poddubnyy
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial. Annals of the rheumatic diseases 83 (5) (2024)
David Kiefer, Kristina Vaupel, Uta Kiltz, Ludwig Hammel, Yvonne M van der Kraan, Suzanne Arends, Xenofon Baraliakos
[German translation and linguistic validation of the modified short questionnaire to assess health-enhancing physical activity (mSQUASH) for patients with axial spondyloarthritis (axSpA)]. Zeitschrift fur Rheumatologie (2024)
Juliette M S Drouet, Clementina López Medina, Benjamin Granger, Bruno Fautrel, Robert B M Landewe, Anna Moltó, Cécile Gaujoux-Viala, Uta Kiltz, Maxime Dougados, Laure Gossec
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients. Rheumatology international 44 (8) (2024)
Weng Seng Warren Fong, Ting Hui Woon, Yu Heng Kwan, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen, Uta Kiltz
Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study. RMD open 10 (1) (2024)
Uta Kiltz, Xenofon Baraliakos, Jan Brandt-Jürgens, Ulf Wagner, Sebastian Lieb, Christian Sieder, Christian Mann, Jüergen Braun
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis: results from phase IV ASTRUM study. Therapeutic advances in musculoskeletal disease 16 (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: Results from a head-to-head randomized phase IIIb study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
David Kiefer, Lucia Schneider, Jüergen Braun, Uta Kiltz, Niklas Kolle, Ioana Andreica, Styliani Tsiami, Bjoern Bühring, Philipp Sewerin, Susanne Herbold, Xenofon Baraliakos
Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis. RMD open 10 (1) (2024)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Ying Ying Leung, Lihi Eder, Ana Maria Orbai, Laura C Coates, Maarten P T de Wit, Josef S Smolen, Uta Kiltz, Penelope Esther Palominos, Juan D Cañete, Rossana Scrivo, Andra Balanescu, Emanuelle Dernis, Sandra Meisalu, Martin Soubrier, Umut Kalyoncu, Laure Gossec
Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study. RMD open 9 (3) (2023)
Uta Kiltz, Désirée van der Heijde, Annelies Boonen, Lianne S Gensler, Theresa Hunter Gibble, Jiaying Guo, Hilde Carlier, Juergen Braun
Clinimetric Validation of the Assessment of Spondyloarthritis International Society Health Index in Patients With Radiographic Axial Spondyloarthritis in Ixekizumab Trials. The Journal of rheumatology (2023)
David Kiefer, Jüergen Braun, Uta Kiltz, Varvara Chatzistefanidi, Daniela Adolf, Ilka Schwarze, Maria Kabelitz, Uwe Lange, Jan Brandt-Jürgens, Edgar Stemmler, Sabine Sartingen, Xenofon Baraliakos
Global functioning in axial spondyloarthritis is stronger associated with disease activity and function than with mobility and radiographic damage. Arthritis care & research (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Uta Kiltz, Kirsten Hoeper, Ludwig Hammel, Sebastian Lieb, Andreas Hähle, Dirk Meyer-Olson
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment. RMD open 9 (1) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy (2023)
Uta Kiltz, Mitsumasa Kishimoto, Jessica A Walsh, Percival Sampaio-Barros, Manish Mittal, Christopher D Saffore, Peter Wung, Fabiana Ganz, Ana Biljan, Denis Poddubnyy
Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2. Rheumatology and therapy (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Stefan Moustakis, Styliani Tsiami, Xenofon Baraliakos, Ioana Andreica, Bjoern Buehring, Jüergen Braun, Uta Kiltz
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care. Therapeutic advances in musculoskeletal disease 15 (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Uta Kiltz, Kirsten Hoeper, Ludwig Hammel, Sebastian Lieb, Andreas Hähle, Dirk Meyer-Olson
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment. RMD open 9 (1) (2023)
Caroline Feldthusen, Magnus Hallström, Alexander d'Elia, Anna Deminger, Uta Kiltz, Helena Forsblad-d'Elia
The ASAS Health Index and Environmental Factors Item Set: validity and reliability of the Swedish translations in Swedish patients with ankylosing spondylitis. Scandinavian journal of rheumatology (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Uta Kiltz, Mitsumasa Kishimoto, Jessica A Walsh, Percival Sampaio-Barros, Manish Mittal, Christopher D Saffore, Peter Wung, Fabiana Ganz, Ana Biljan, Denis Poddubnyy
Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2. Rheumatology and therapy (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Imke Redeker, Robert B M Landewe, Désirée Mfm van der Heijde, Josef S Smolen, Annelies Boonen, Maxime Dougados, Jüergen Braun, Uta Kiltz
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort. RMD open 9 (4) (2023)
Michaela Köhm, Ann Christina Foldenauer, Tanja Rossmanith, Herbert Kellner, Uta Kiltz, Gerd-Rüdiger R Burmester, David M Kofler, Jan Brandt, Stephanie Finzel, Raoul Bergner, Maren Sieburg, Frank Behrens, null null
Differences in treatment response between female and male psoriatic arthritis patients during IL-12/23 therapy with or without methotrexate: post hoc analysis of results from the randomised MUST trial. RMD open 9 (4) (2023)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert opinion on biological therapy 23 (2) (2023)
Ioana Andreica, Iulia Roman, Imke Redeker, Xenofon Baraliakos, Jüergen Braun, Uta Kiltz
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study. RMD open 9 (2) (2023)
Uta Kiltz, Kirsten Hoeper, Ludwig Hammel, Sebastian Lieb, Andreas Hähle, Dirk Meyer-Olson
Work participation in patients with axial spondyloarthritis: high prevalence of negative workplace experiences and long-term work impairment. RMD open 9 (1) (2023)
Iulia Roman, Ioana Andreica, Xenofon Baraliakos, Imke Redeker, Uta Kiltz, Jürgen Braun
SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD. Therapeutic advances in musculoskeletal disease 14 (2022)
Uta Kiltz, Eerik Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology (2022)
Neelam Hassan, Leonieke J J van Mens, Uta Kiltz, Laura Andreoli, Concha Delgado-Beltran, Pavel V Ovseiko, Laure Gossec, Laura C Coates
Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences? RMD open 8 (1) (2022)
Bjoern Bühring, Nadine Al-Azem, Uta Kiltz, Martin Fruth, Ioana Andreica, David Kiefer, Styliani Tsiami, Xenofon Baraliakos, Jüergen Braun
High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases. The Journal of rheumatology (2022)
Ioana Andreica, Arturo Blazquez-Navarro, Jan Sokolar, Moritz Anft, Uta Kiltz, Stephanie Pfaender, Elena Vidal Blanco, Timm Westhoff, Nina Babel, Ulrik Stervbo, Xenofon Baraliakos
Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination. RMD open 8 (2) (2022)
Casper Webers, Uta Kiltz, Jüergen Braun, Désirée Mfm van der Heijde, Annelies Boonen
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter? Rheumatology (Oxford, England) (2022)
Pavel V Ovseiko, Laure Gossec, Laura Andreoli, Uta Kiltz, Leonieke van Mens, Neelam Hassan, Marike van der Leeden, Heidi J Siddle, Alessia Alunno, Iain B McInnes, Nemanja S Damjanov, Florence Apparailly, Caroline Ospelt, Irene E van der Horst-Bruinsma, Elena Nikiphorou, Katie L Druce, Zoltán Szekanecz, Alexandre Sepriano, Tadej Avcin, George Bertsias, Georg Schett, Anne-Maree Keenan, Linda H Pololi, Laura C Coates
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD open 8 (2) (2022)
Josef S Smolen, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewe, Filip E Van den Bosch, Boryana Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, Floris A van Gaalen, Pál Géher, Lianne Gensler, Josef Hermann, Manouk de Hooge, Marketa Husakova, Uta Kiltz, Clementina López Medina, Pedro M Machado, Helena Marzo-Ortega, Anna Moltó, Victoria Navarro-Compán, Michael John Nissen, Fernando M Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martin Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziadé, Désirée Mfm van der Heijde
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Annals of the rheumatic diseases (2022)
Florian Lucasson, Uta Kiltz, Umut Kalyoncu, Ying Ying Leung, Penelope Esther Palominos, Juan D Cañete, Rossana Scrivo, Andra Balanescu, Emanuelle Dernis, Sandra Meisalu, Adeline Ruyssen-Witrand, Martin Soubrier, Sibel Zehra Aydın, Lihi Eder, Inna Gaydukova, Ennio Lubrano, Pascal Richette, Elaine Husni, Laura C Coates, Maarten P T de Wit, Josef S Smolen, Ana Maria Orbai, Laure Gossec
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries. RMD open 8 (1) (2022)
Helena Marzo-Ortega, Victoria Navarro-Compán, Servet Akar, Uta Kiltz, Zoë Clark, Elena Nikiphorou
An improved understanding of sex and gender is crucial for precision rheumatology. Clinical rheumatology 41 (12) (2022)
Jüergen Braun, Uta Kiltz, Atul Deodhar, Tetsuya Tomita, Maxime Dougados, Rebecca Bolce, David Sandoval, Chen-Yen Lin, Jessica Walsh
Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST. RMD open 8 (2) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Management of Axial Spondyloarthritis - Insights into Upadacitinib. Drug design, development and therapy 16 (2022)
Uta Kiltz, Styliani Tsiami, Xenofon Baraliakos, Ioana Andreica, David Kiefer, Jürgen Braun
Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases. Therapeutic advances in musculoskeletal disease 14 (2022)
Robin Kempin, Jutta G Richter, Anna Schlegel, Xenofon Baraliakos, Styliani Tsiami, Bjoern Buehring, David Kiefer, Jüergen Braun, Uta Kiltz
Monitoring of Disease Activity With a Smartphone App in Routine Clinical Care in Patients With Axial Spondyloarthritis. The Journal of rheumatology 49 (8) (2022)
D Kiefer, J Braun, Uta Kiltz
[Axial spondyloarthritis : Update on management based on the interdisciplinary S3 guidelines on axial spondyloarthritis including early forms and ankylosing spondylitis]. Zeitschrift fur Rheumatologie 81 (3) (2022)
Victoria Navarro-Compán, Anne Boel, Annelies Boonen, Phillip J Mease, Maxime Dougados, Uta Kiltz, Robert B M Landewe, Xenofon Baraliakos, Wilson Bautista-Molano, Praveena Chiowchanwisawakit, Hanne Dagfinrud, Lara Fallon, Marco Garrido-Cumbrera, Lianne Gensler, Bassel Kamal ElZorkany, Nigil Haroon, Elenore Judy B Uy, Pedro M Machado, Walter Maksymowych, Anna Moltó, Natasha de Peyrecave, Denis Poddubnyy, Mikhail Protopopov, Josef S Smolen, In-Ho Song, Salima van Weely, Désirée Mfm van der Heijde
Instrument selection for the ASAS core outcome set for axial spondyloarthritis. Annals of the rheumatic diseases (2022)
Silke Neusser, Anja Neumann, Pauline Zur Nieden, Christian Speckemeier, Sarah Schlierenkamp, Anke Walendzik, Ute Karbach, Ioana Andreica, Kristina Vaupel, Xenofon Baraliakos, Uta Kiltz
Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review. RMD open 8 (2) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Silke Neusser, Anja Neumann, Pauline Zur Nieden, Christian Speckemeier, Sarah Schlierenkamp, Anke Walendzik, Ute Karbach, Ioana Andreica, Kristina Vaupel, Xenofon Baraliakos, Uta Kiltz
Facilitators and barriers of vaccine uptake in patients with autoimune inflammatory rheumatic disease: a scoping review. RMD open 8 (2) (2022)
Clementina López Medina, Sylvie Chevret, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Alessandro Biglia, Kim Tae-Jong, Kishimoto Mitsumasa, Fernando M Pimentel-Santos, Jieruo Gu, Laura Muntean, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián E Ibáñez-Vodnizza, Wilson Bautista Molano, Walter P Maksymowych, Pedro M Machado, Robert B M Landewe, Désirée Mfm van der Heijde, Maxime Dougados
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study. RMD open 7 (3) (2022)
Uta Kiltz, Eerik P Ahomaa, Salima F E van Weely, David Kiefer, Bjoern Bühring, Xenofon Baraliakos, Jüergen Braun
Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. The Journal of rheumatology 50 (3) (2022)
Uta Kiltz, T Wiatr, D Kiefer, X Baraliakos, J Braun
[Effect of multimodal rheumatologic complex treatment in patients with axial spondylarthritis : A systematic evaluation with standardized outcome parameters, such as the ASAS Health Index]. Zeitschrift fur Rheumatologie (2022)
Maria Sole Chimenti, Rieke E Alten, Maria Antonietta D'Agostino, Elisa Gremese, Uta Kiltz, Ennio Lubrano, Mireia Moreno Martínez-Losa, Thao Pham, Roberta Ramonda, Francesca Romana Spinelli, Chiara Perella, Laura Andreoli
Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients. RMD open 7 (3) (2022)
Uta Kiltz, Aylin Celik, Styliani Tsiami, Bjoern Buehring, Xenofon Baraliakos, Ioana Andreica, David Kiefer, Juergen Braun
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study. RMD open 7 (1) (2021)
Jüergen Braun, Xenofon Baraliakos, Uta Kiltz
Treat-to-target in axial spondyloarthritis - what about physical function and activity? Nature reviews. Rheumatology 17 (9) (2021)
Jüergen Braun, Uta Kiltz, Xenofon Baraliakos
Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning. Annals of the rheumatic diseases (2021)
Clementina López Medina, Anna Moltó, Joachim Sieper, Tuncay Duruöz, Uta Kiltz, Bassel Elzorkany, Najia Hajjaj-Hassouni, Ruben Burgos-Vargas, José Maldonado-Cocco, Nelly Ziadé, Meghna Gavali, Victoria Navarro-Compan, Shue-Fen Luo, Sara Monti, Kim Tae-Jong, Mitsumasa Kishimoto, F M Pimentel-Santos, Jieruo Gu, Ruxandra Schiotis, Floris A van Gaalen, Pál Geher, Marina Magrey, Sebastián Eduardo Ibáñez Vodnizza, Wilson Bautista Molano, Walter Maksymowych, Pedro M Machado, Robert Landewé, Désirée Mfm van der Heijde, Maxime Dougados
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD open 7 (1) (2021)
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Phillip J Mease, Uta Kiltz, Maxime Dougados, Robert B M Landewe, Désirée Mfm van der Heijde
Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey. The Journal of rheumatology 48 (12) (2021)
Uta Kiltz, Daniel Wendling, Jüergen Braun
Dr. Kiltz, et al reply. The Journal of rheumatology 48 (5) (2021)
Uta Kiltz, Jüergen Braun
Correspondence on "Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial" by Molto et al. Annals of the rheumatic diseases (2021)
Uta Kiltz, David Kiefer, Jürgen Braun, Anne-Kathrin Rausch-Osthoff, Susanne Herbold, Meike Klinger, Agnes Kocher, Valerie Nell-Duxneuner, Stefan Reichenbach, Tanja Stamm, Patricia Steffens-Korbanka, Karin Niedermann
[Translation of the 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis and linguistic validation in German-speaking countries with healthcare professionals]. Zeitschrift fur Rheumatologie (2021)
Laura C Coates, Danielle E Robinson, Ana Maria Orbai, Uta Kiltz, Ying-Ying Leung, Penelope Palominos, Juan D Cañete, Rossana Scrivo, Andra Balanescu, Emmanuelle Dernis, Sandra Meisalu, Adeline Ruyssen-Witrand, Lihi Eder, Maarten de Wit, Josef S Smolen, Ennio Lubrano, Laure Gossec
What influences patients' opinion of remission and low disease activity in psoriatic arthritis? Principal component analysis of an international study. Rheumatology (Oxford, England) 60 (11) (2021)
Uta Kiltz, Annelies Boonen, Désirée Mfm van der Heijde, Wilson Bautista Molano, Ruben Burgos Vargas, Praveena Chiowchanwisawakit, Bassel El-Zorkany, Inna Gaydukova, Pal Geher, Laure Gossec, Michele Gilio, Simeon Grazio, Jieruo Gu, Muhammad Asim Khan, Tae Jong Kim, Walter P Maksymowych, Helena Marzo-Ortega, Victoria Navarro-Compán, Salih Ozgocmen, Dimos Patrikos, Fernando Manuel Pimentel-Santos, John Reveille, Schirmer Michael, Simon Stebbings, Filip E Van den Bosch, Ulrich Weber, Juergen Braun
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis. Rheumatology (Oxford, England) (2021)
Xenofon Baraliakos, A Ghadir, Martin Fruth, Uta Kiltz, Imke Redeker, Jüergen Braun
Which Magnetic Resonance Imaging Lesions in the Sacroiliac Joints Are Most Relevant for Diagnosing Axial Spondyloarthritis? A Prospective Study Comparing Rheumatologists' Evaluations With Radiologists' Findings. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Uta Kiltz, D L Keininger, E A Holdsworth, N Booth, O Howell, N Modi, H Tian, P G Conaghan
Real-world effectiveness and rheumatologist satisfaction with secukinumab in the treatment of patients with axial spondyloarthritis. Clinical rheumatology (2021)
Ioana Andreica, David Kiefer, Guenther A Rezniczek, Robert Jast, Bjoern Buehring, Uta Kiltz, Xenofon Baraliakos, Juergen Braun
Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. Annals of the rheumatic diseases (2020)
Uta Kiltz, James Cheng-Chung Wei, Désirée Mfm van der Heijde, Filip E Van den Bosch, Jessica A Walsh, Annelies Boonen, Lianne S Gensler, Theresa Hunter, Hilde Carlier, Yan Dong, Xiaoqi Li, Rebecca Bolce, Vibeke Strand, Jüergen Braun
Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. The Journal of rheumatology 48 (2) (2020)
Uta Kiltz, Daniel Wendling, Jüergen Braun
ASAS Health Index: The "All in One" for Spondyloarthritis Evaluation? The Journal of rheumatology 47 (10) (2020)
Jessica A Walsh, Marina N Magrey, Xenofon Baraliakos, Kentaro Inui, Meng-Yu Weng, Ennio Lubrano, Désirée van der Heijde, Annelies Boonen, Lianne S Gensler, Vibeke Strand, Jürgen Braun, Theresa Hunter Gibble, Xiaoqi Li, Baojin Zhu, Luis León, David Marcelino Sandoval Calderon, Uta Kiltz
Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial. Arthritis care & research (2020)
Ana Maria Orbai, Jamie Perin, Clémence Gorlier, Laura C Coates, Uta Kiltz, Ying Ying Leung, Penelope E Palominos, Juan D Cañete, Rossana Scrivo, Andra Balanescu, Emmanuelle Dernis, Sandra Tälli, Adeline Ruyssen-Witrand, Martin Soubrier, Sibel Zehra Aydın, Lihi Eder, Inna Gaydukova, Ennio Lubrano, Umut Kalyoncu, Pascal Richette, M Elaine Husni, Josef S Smolen, Maarten de Wit, Laure Gossec
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries. Arthritis care & research 72 (12) (2020)
Juergen Braun, Uta Kiltz, Xenofon Baraliakos
Observation by Magnetic Resonance Imaging of Sacroiliac Joint Ankylosis in Young Spondyloarthritis Patients Receiving Biologic Therapy: Comment on the Article by Bray et al. Arthritis & rheumatology (Hoboken, N.J.) 71 (12) (2019)
Uta Kiltz, Robert B M Landewé, Désirée Mfm van der Heijde, Martin Rudwaleit, Michael H Weisman, Nurullah Akkoc, Annelies Boonen, Jan Brandt, Philippe Carron, Maxime Dougados, Laure Gossec, Merryn Jongkees, Pedro M Machado, Helena Marzo-Ortega, Anna Moltó, Victoria Navarro-Compán, Karin Niederman, Percival Degrava Sampaio-Barros, Gleb Slobodin, Filip E Van den Bosch, Astrid van Tubergen, Salima van Weely, Dieter Wiek, Juergen Braun
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis. Annals of the rheumatic diseases 79 (2) (2019)
Jüergen Braun, Xenofon Baraliakos, Uta Kiltz, Klaus Krüger, Gerd-Rüdiger R Burmester, Siegfried Wassenberg, Matthias H Thomas
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis. The Journal of rheumatology 47 (1) (2019)
Uta Kiltz, Christine von Zabern, Xenofon Baraliakos, Frank Heldmann, Bernd Mintrop, Michael Sarholz, Dietmar Krause, Friedrich Dybowski, Ludwig Kalthoff, Jürgen Braun
Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study. Arthritis research & therapy 19 (1) (2017)